| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 05/26/2005 | WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 05/26/2005 | WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 05/26/2005 | US20050114109 STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND |
| 05/26/2005 | US20050112676 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography |
| 05/26/2005 | CA2805859A1 Il-18 binding proteins |
| 05/26/2005 | CA2544816A1 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 05/25/2005 | EP1532239A2 Methods and compositions for targeting secretory lysosomes |
| 05/25/2005 | CN1618837A Preparation method of polyethylene carboxylic acid and its use |
| 05/19/2005 | WO2005045439A1 Binding assay components |
| 05/19/2005 | WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 05/19/2005 | US20050106727 Peptides for enhanced cell attachment and growth |
| 05/19/2005 | US20050106553 Rendering material suitable for storage via spraying into hot gas stream an aqueous mixture and carrier, drying mixture to particles , separating partiles from gas stream; storage of materials by incorporating them into water-soluble or water-swellable substance |
| 05/19/2005 | US20050106401 Functionalized silicon surfaces |
| 05/18/2005 | EP1530582A2 Diagnosis of kidney damage and protection against same |
| 05/17/2005 | US6893645 Process to make a sustained release formulation |
| 05/12/2005 | WO2004110370A3 Etiologic agnet for sow infertility syndrome |
| 05/12/2005 | WO2004106497A3 Imageable animal model of sars infection |
| 05/12/2005 | WO2004076631A3 Biologically active native biomatrix composition |
| 05/10/2005 | US6890765 Particles for immunoassays and methods for treating the same |
| 05/06/2005 | WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof |
| 05/06/2005 | WO2004112727A3 Aav virions with decreased immunoreactivity and uses therefor |
| 05/05/2005 | US20050095690 Entrapment of biomolecules and inorganic nanoparticles by biosilicification |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095224 Compositions and method for treating hepatitis virus infection |
| 05/04/2005 | EP1080368B1 Molecular rod and uses |
| 05/03/2005 | US6887847 Virus derived antimicrobial peptides |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004075988A3 Methods of immunomodulation in animals |
| 04/28/2005 | WO2004064784A3 Composition and method for preventing or treating a virus infection |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | CN1198837C Purification of tissue plasminogen activator (tPA) |
| 04/21/2005 | WO2005035585A1 Support having affinity for antibody |
| 04/21/2005 | WO2005035554A1 Dioxin-binding material and method of detecting or quantifying dioxin |
| 04/21/2005 | WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/21/2005 | WO2004052273A3 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 04/21/2005 | WO2003067219A3 STRUCTURE OF INTEGRIN αV-β3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/19/2005 | US6881804 Porous, molecularly imprinted polymer and a process for the preparation thereof |
| 04/19/2005 | US6881408 Removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use. |
| 04/14/2005 | WO2005033281A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | WO2005033274A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | WO2005033146A1 Attachment of cells to surfaces |
| 04/14/2005 | US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079500 Using microarray stratification and spectrum analysis to identify, quantify and/or characterizing proteins in mixture |
| 04/14/2005 | CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | CA2526425A1 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 04/13/2005 | EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins |
| 04/13/2005 | EP0774971B1 Synthetic peptide inhibitors of hiv transmission |
| 04/13/2005 | CN1196798C High density protein arrays for screening of protein activity |
| 04/12/2005 | CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 04/07/2005 | WO2005030979A2 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays |
| 04/07/2005 | US20050075483 Vancomycin derivatives linked with disaccharide sugar, obtained by deprotecting a protected glycopeptide, by sulfonation, replacement; preparing a glycopeptide by glycosylation of an aglycone derived from glycopeptide antibiotic |
| 04/07/2005 | US20050075102 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074460 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 04/07/2005 | US20050074429 Optimal compositions and methods thereof for treating HCV infections |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/06/2005 | EP1519748A1 Microparticle with cd28-specific monoclonal antibodies |
| 04/06/2005 | CN1603337A Chemical synthesis method for inducing antibody immunogen against cell adhesion growth factor RGD |
| 04/05/2005 | US6875620 Tiling process for constructing a chemical array |
| 03/31/2005 | WO2005029076A2 Nanoparticle conjugates and method of production thereof |
| 03/31/2005 | WO2005016949A3 Sialic acid derivatives |
| 03/31/2005 | WO2005016283A3 Peptides for enhanced cell attachment and growth |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | CA2539501A1 Nanoparticle conjugates and method of production thereof |
| 03/31/2005 | CA2538998A1 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 03/29/2005 | US6872520 Peptide for use in the detection of viral infection and diseases |
| 03/29/2005 | CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 03/24/2005 | WO2005026733A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | WO2005025516A2 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | WO2004111259A3 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/24/2005 | WO2004101766A3 Grp94-based compositions and methods of use thereof |
| 03/24/2005 | WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 03/24/2005 | WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity |
| 03/24/2005 | WO2004024777A8 Hydroxyalkyl starch derivatives |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | CA2538076A1 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/23/2005 | EP1515989A1 Immunogenic conjugates |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/17/2005 | US20050059087 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/17/2005 | US20050058993 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058992 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 03/16/2005 | EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 03/16/2005 | EP1513866A2 Assay conjugate and uses thereof |
| 03/10/2005 | US20050054015 Information enhanced antibody arrays |
| 03/10/2005 | US20050053977 Methods for treating lentivirus infections |
| 03/10/2005 | US20050053928 Arrays for detecting nucleic acids |
| 03/10/2005 | US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 03/10/2005 | CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them |
| 03/09/2005 | EP1511760A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 03/09/2005 | EP1429798A4 Optimal compositions and methods thereof for treating hcv infections |